36Moreover, that interpretation of the provision in question is, as the Advocate General pointed out in points 56 to 60 of his Opinion, in accordance with the objectives which Directive 2001/83 seeks to attain, namely, the elimination of hindrances to trade in medicinal products between the Member States and the protection of public health.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.